HRT Financial’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRS
SL
HRT Financial's KLRS Position: Q3 2026 in Review
HRT Financial increased its Kalaris Therapeutics (KLRS) stake by 86% in Q3 2026, buying an estimated $45.8K and bringing the position to 25,560 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #4229.
HRT Financial first reported a position in KLRS in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.58M in Q2 2021. 54 funds tracked by Wall St. Rank hold KLRS as of Q3 2026.
- HRT Financial held 25,560 shares of Kalaris Therapeutics worth $73K as of Q3 2026.
- HRT Financial bought 11,837 Kalaris Therapeutics shares in Q3 2026, an estimated $45.8K.
- Kalaris Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4229 holding.
- HRT Financial first reported a position in Kalaris Therapeutics in Q2 2021 and has held it in 8 quarters since.
- HRT Financial's Kalaris Therapeutics position peaked at $1.58M in Q2 2021.
- 54 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.